Key result
Epicardial adipose tissue and its association with metabolic syndrome will be evaluated in this systematic review and meta-analysis protocol, which currently reports no clinical results.
Why the study?
Is epicardial adipose tissue associated with the presence of metabolic syndrome and increased risk of cardiovascular outcomes in adults?
Systematic Review
Is epicardial adipose tissue associated with the presence of metabolic syndrome and increased risk of cardiovascular outcomes in adults?
This protocol outlines a planned systematic review and meta-analysis to evaluate the association between epicardial adipose tissue and metabolic syndrome, as well as related cardiovascular outcomes.
No results yet from this protocol; leaves open epicardial adipose tissue's association with metabolic syndrome and cardiovascular outcomes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Roever et al. (2018) conducted a systematic review in Metabolic syndrome. Epicardial adipose tissue (EAT) vs. Unexposed individuals (low or absent EAT) was evaluated on Association of EAT with the presence of metabolic syndrome, cardiovascular disease outcomes, and death (CV mortality, all-cause mortality). Epicardial adipose tissue and its association with metabolic syndrome will be evaluated in this systematic review and meta-analysis protocol, which currently reports no clinical results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: